2GT-30985-95133 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-05
Registered in v-safe
2021-01-05
Dose 1 — Pfizer-BioNTech
2021-01-05
Health check-in — day 0, dose 1
Feeling: Good · Site: Pain · Fatigue or tiredness

Adult check-in
2021-01-06
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Fatigue or tiredness

Adult check-in
2021-01-07
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-09
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-10
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-19
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-26
Survey response — day 21, dose 1
MedDRA: Lymphadenopathy — Feeling: Good

Free text: Bilateral axillary swollen lymph nodes

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-27
Dose 2 — Pfizer-BioNTech
2021-01-28
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-29
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-31
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-02-01
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-02-02
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Joint pains · Be unable to do your normal daily activities

Adult check-in
2021-02-03
Health check-in — day 7, dose 2
Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-02-10
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-18
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-24
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-03-03
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-03-10
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-28
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-07-28
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-10-01
Dose 3 — Pfizer-BioNTech
2021-10-01
Health check-in — day 0, dose 3
Feeling: Good · None

Adult check-in
2021-10-02
Survey response — days 1–6 daily, dose 3
MedDRA: Dyspnoea exertional — Feeling: Fair

Free text: Shortness of breath upon mild exercise

MedDRA releases: 2024-11 · check-in free text available
2021-10-03
Survey response — days 1–6 daily, dose 3
MedDRA: Chest pain, Dyspnoea exertional — Feeling: Fair · Be unable to do your normal daily activities

Free text: Chest pain & shortness of breath when walking casually for greater than 10 minutes.

MedDRA releases: 2024-11 · check-in free text available
2021-10-04
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-10-05
Survey response — days 1–6 daily, dose 3
MedDRA: Dyspnoea, Palpitations — Feeling: Fair

Free text: Shortness of breath and palpitations

MedDRA releases: 2024-11 · check-in free text available
2021-10-06
Survey response — days 1–6 daily, dose 3
MedDRA: Dyspnoea, Palpitations — Feeling: Fair

Free text: Shortness of breath and palpitations

MedDRA releases: 2024-11 · check-in free text available
2021-10-07
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-10-08
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2021-10-17
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2021-11-05
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2022-04-01
Survey response — 6 months, dose 3
MedDRA: Intermenstrual bleeding, Uterine dilation and curettage — Feeling: Good · Get care from a doctor or other healthcare professional

Free text: Symptoms: Metrorrhagia · Healthcare visit (other): D&C

MedDRA releases: 2024-11 · check-in free text available
2022-04-01
Report sent to call center — 6 months, dose 3
Get care from a doctor or other healthcare professional

1 call case(s)
2022-04-21
Call successful
Participant prefers to complete VAERS report online
2022-10-01
Health check-in — 12 months, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-05	Pfizer-BioNTech
2	2021-01-27	Pfizer-BioNTech
3	2021-10-01	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2022-04-01	Successful 2022-04-21	Participant prefers to complete VAERS report online

Free text

Release 2 — day 21, dose 1

2021-01-26

Symptoms: Bilateral axillary swollen lymph nodes

Release 9 — days 1–6 daily, dose 3

2021-10-02

Systemic reaction (other): Shortness of breath upon mild exercise

2021-10-03

Systemic reaction (other): Chest pain & shortness of breath when walking casually for greater than 10 minutes.

Release 10 — days 1–6 daily, dose 3

2021-10-05

Systemic reaction (other): Shortness of breath and palpitations

2021-10-06

Systemic reaction (other): Shortness of breath and palpitations

Release 11 — 6 months, dose 3

2022-04-01

Symptoms: Metrorrhagia

Healthcare visit (other): D&C

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Uterine dilation and curettage	·	·	✓
SD	Intermenstrual bleeding	·	·	✓
SD	Lymphadenopathy	✓	✓	✓
SRO	Chest pain	·	·	✓
SRO	Dyspnoea	·	·	✓
SRO	Dyspnoea exertional	·	·	✓
SRO	Palpitations	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release